470 related articles for article (PubMed ID: 25568448)
21. Epigenetic regulation of BDNF expression according to antidepressant response.
Lopez JP; Mamdani F; Labonte B; Beaulieu MM; Yang JP; Berlim MT; Ernst C; Turecki G
Mol Psychiatry; 2013 Apr; 18(4):398-9. PubMed ID: 22547115
[No Abstract] [Full Text] [Related]
22. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
[TBL] [Abstract][Full Text] [Related]
23. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
[TBL] [Abstract][Full Text] [Related]
24. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
Domschke K; Lawford B; Laje G; Berger K; Young R; Morris P; Deckert J; Arolt V; McMahon FJ; Baune BT
Int J Neuropsychopharmacol; 2010 Feb; 13(1):93-101. PubMed ID: 19236730
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
Farley S; Dumas S; El Mestikawy S; Giros B
Neuropharmacology; 2012 Jan; 62(1):503-17. PubMed ID: 21945287
[TBL] [Abstract][Full Text] [Related]
26. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
[TBL] [Abstract][Full Text] [Related]
27. Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine.
Gassen NC; Fries GR; Zannas AS; Hartmann J; Zschocke J; Hafner K; Carrillo-Roa T; Steinbacher J; Preißinger SN; Hoeijmakers L; Knop M; Weber F; Kloiber S; Lucae S; Chrousos GP; Carell T; Ising M; Binder EB; Schmidt MV; Rüegg J; Rein T
Sci Signal; 2015 Nov; 8(404):ra119. PubMed ID: 26602018
[TBL] [Abstract][Full Text] [Related]
28. [Major depressive disorders and BDNF (brain-derived neurotrophic factor)].
Shimizu E; Hashimoto K; Iyo M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):147-50. PubMed ID: 15291244
[TBL] [Abstract][Full Text] [Related]
29. Effects of antidepressant treatment on mice lacking brain-derived neurotrophic factor expression through promoter IV.
Sakata K; Mastin JR; Duke SM; Vail MG; Overacre AE; Dong BE; Jha S
Eur J Neurosci; 2013 Jun; 37(11):1863-74. PubMed ID: 23406189
[TBL] [Abstract][Full Text] [Related]
30. [Epigenetic regulation in depression].
Otsuki K; Uchida S; Hobara T; Yamagata H; Watanabe Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):181-6. PubMed ID: 23012885
[TBL] [Abstract][Full Text] [Related]
31. Noncoding RNAs in Depression.
Lin R; Turecki G
Adv Exp Med Biol; 2017; 978():197-210. PubMed ID: 28523548
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic alterations in depression and antidepressant treatment.
Menke A; Binder EB
Dialogues Clin Neurosci; 2014 Sep; 16(3):395-404. PubMed ID: 25364288
[TBL] [Abstract][Full Text] [Related]
33. Inherited behaviors, BDNF expression and response to treatment in a novel multifactorial rat model for depression.
Gersner R; Gal R; Levit O; Moshe H; Zangen A
Int J Neuropsychopharmacol; 2014 Jun; 17(6):945-55. PubMed ID: 24513109
[TBL] [Abstract][Full Text] [Related]
34. BDNF methylation and depressive disorder in acute coronary syndrome: The K-DEPACS and EsDEPACS studies.
Kim JM; Stewart R; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
Psychoneuroendocrinology; 2015 Dec; 62():159-65. PubMed ID: 26313133
[TBL] [Abstract][Full Text] [Related]
35. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression.
Kunugi H; Hori H; Adachi N; Numakawa T
Psychiatry Clin Neurosci; 2010 Oct; 64(5):447-59. PubMed ID: 20923424
[TBL] [Abstract][Full Text] [Related]
36. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.
Gardier AM
Behav Pharmacol; 2009 Feb; 20(1):18-32. PubMed ID: 19179848
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs and depression.
Mouillet-Richard S; Baudry A; Launay JM; Kellermann O
Neurobiol Dis; 2012 May; 46(2):272-8. PubMed ID: 22226785
[TBL] [Abstract][Full Text] [Related]
38. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
Kozisek ME; Middlemas D; Bylund DB
Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
[TBL] [Abstract][Full Text] [Related]
39. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
40. BDNF and COX-2 participate in anti-depressive mechanisms of catalpol in rats undergoing chronic unpredictable mild stress.
Wang JM; Yang LH; Zhang YY; Niu CL; Cui Y; Feng WS; Wang GF
Physiol Behav; 2015 Nov; 151():360-8. PubMed ID: 26255123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
